- 英文名称Ethyl 7,8,9-Trihydroxy-3,5-Dioxo-1,2,3,5-Tetrahydrocyclopenta[c]Isochromene-1-Carboxylate
- 中文名称7,8,9-三羟基-3,5-二氧代-1,2-二氢环戊烯并[c]异苯并吡喃-1-羧酸乙酯
- IUPAC名称ethyl 7,8,9-trihydroxy-3,5-dioxo-1,2,3,5-tetrahydrocyclopenta[c]isochromene-1-carboxylate
- 其它别名Ethyl Brevifolincarboxylate; Cyclopenta[c][2]Benzopyran-1-Carboxylic Acid, 1,2,3,5-Tetrahydro-7,8,9-Trihydroxy-3,5-Dioxo-, Ethyl Ester; Ethyl Brevifolincarboxylateethyl Brevifolincarboxy
- CAS编号107646-82-2
- MFCD编号:MFCD34167429
- 分子式:C15H12O8分子量:320.25
- 产品CID: 114526
- 产品分类医药中间体
海关参考信息
- 2905199090-其他饱和一元醇
2905399099-其他二元醇
2905499000-其他多元醇
2905590090-其他无环醇的卤化、磺化等衍生物 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2002165207-A1
优先权日:2001-05-02
标题 :Compositions and methods for the treatment of diabetic neuropathy
发明人:ROSENBLOOM RICHARD
摘要:Compositions and a method for the treatment of diabetic neuropathy is disclosed. The compositions comprise a mixture of a compound that promotes synthesis of nerve growth factor, an aldose reductase inhibitor and an antioxidant, optionally formulated in a pharmaceutically acceptable carrier. This combination of active agents provides significant, effective relief of the symptoms of diabetic neuropathy, as well as at least partial recovery of lost neurological function in some cases. In addition, the compositions of the present invention, when used in effective amounts to treat diabetic neuropathy, do not exhibit the severe side effects of many prior art compositions proposed for treatment of this ailment. n In a second aspect, a method for the administration of a composition in accordance with the present invention for the treatment of diabetic neuropathy is disclosed. In the method, an effective amount of the composition of the invention is administered on a regular basis over a period of time sufficient to provide the beneficial effects of relief from the symptoms of diabetic neuropathy, as well as at least some recovery of the damaged nerve tissues.